Tags
joint repair
3 results found in 49ms
  • ‹‹
  • 1
  • ››
ChondroFiller injection safety: what the evidence showsChondroFiller injection safety: what the evidence shows
Over 19,000 ChondroFiller injections have been administered globally with no serious adverse effects reported; reoperation rates of 3–8% fall well below surgical alternatives such as microfracture (up to 41%) and ACI/MACI (up to 37%).Over 19,000 ChondroFiller injections have been administered globally with no serious adverse effects reported; reoperation rates of 3–8% fall well below surgical alternatives such as microfracture (up to 41%) and ACI/MACI (up to 37%).
ChondroFiller vs PRP for focal cartilage defectsChondroFiller vs PRP for focal cartilage defects
Focal cartilage defects and diffuse cartilage loss are different problems requiring different solutions. ChondroFiller, a collagen scaffold, physically occupies and stabilises focal voids, recruiting repair cells over 12–24 months. PRP releases growth factors to reduce inflammation but cannot fill a structural gap. Imaging reveals which mechanism addresses the patient's underlyingFocal cartilage defects and diffuse cartilage loss are different problems requiring different solutions. ChondroFiller, a collagen scaffold, physically occupies and stabilises focal voids, recruiting repair cells over 12–24 months. PRP releases growth factors to reduce inflammation but cannot fill a structural gap. Imaging reveals which mechanism addresses the patient's underlying problem.
Molecular Gatekeepers: How Enzymes Orchestrate Cartilage Renewal and BreakdownMolecular Gatekeepers: How Enzymes Orchestrate Cartilage Renewal and Breakdown
This article explores the crucial balance of cartilage matrix turnover governed by enzymes such as MMPs, ADAMTS, and TIMPs, which regulate cartilage health and joint function. Disruption in this balance leads to cartilage degradation and joint diseases like osteoarthritis. Advances in molecular tools, including S-propargyl-cysteine, offer precise control over enzymeThis article explores the crucial balance of cartilage matrix turnover governed by enzymes such as MMPs, ADAMTS, and TIMPs, which regulate cartilage health and joint function. Disruption in this balance leads to cartilage degradation and joint diseases like osteoarthritis. Advances in molecular tools, including S-propargyl-cysteine, offer precise control over enzyme activity, paving the way for innovative treatments. Insights from Professor Paul Lee and the MSK Doctors highlight evidence-based,...
3 results found in 49ms
  • ‹‹
  • 1
  • ››